Convection Enhanced Localized Administration of PRX321 With Real-time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1) (CLARITY-1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00797940
Recruitment Status : Withdrawn (No funding for study)
First Posted : November 25, 2008
Last Update Posted : December 3, 2012
Information provided by (Responsible Party):
Sophiris Bio Corp

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
  Recruitment Status : Withdrawn
  Estimated Primary Completion Date : December 2010
  Study Completion Date : No date given